Ypsomed Holding AG (LTS:0QLQ) FFO


LTS:0QLQ Ypsomed Holding AG LTS:0QLQ
82 GF Score
Price CHF359.40
GF Value CHF397.17
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ypsomed Holding AG FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0QLQ
82GF Score
Ypsomed Holding AG LTS:0QLQ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ypsomed Holding AG (LTS:0QLQ) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF359.40 is trading 9.5% below its estimated GF Value™ of CHF397.17. GuruFocus considers Ypsomed Holding AG to be Modestly Undervalued.

Key valuation signals for LTS:0QLQ:

  • FFO:
  • GF Value™: CHF397.17 vs. price of CHF359.40 (9.5% below fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the LTS:0QLQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
82GF Score

Get the complete analysis for LTS:0QLQ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF359.40
Price
CHF397.17
GF Value